Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Bausch + Lomb has appointed Rodney (Rod) Unsworth as a new president of Asia-Pacific (APAC), effective July 1, 2010.
Subscribe to our email newsletter
Mr Unsworth will succeed David Edwards, who will continue to advise the company during a transition period.
Mr Unsworth served as president of Asia-Pacific, for Schering-Plough from 2004 until its merger with Merck in 2009. In that role, he led a performance turnaround in key markets such as China.
From 1995 to 2002, he was associated with Pharmacia as president of Asia-Pacific; global vice president of Ophthalmology and Metabolic Diseases; and managing director of Pharmacia & Upjohn Australia.
Earlier, in 1972 he established Delta West, the Australian pharmaceuticals company, and worked there as its chairman and managing director for 20 years. Later the company was acquired by Upjohn in 1992.
Brent Saunders, CEO of Bausch + Lomb, said: “Rod has an extensive and successful record of driving transformational change in global health care companies, with a particular focus on Asia-Pacific. His counsel and leadership will be extremely valuable as we work to build B+L into a high-performance competitor in Asia and worldwide.
“We thank David for his contributions to the company and for establishing a strong foundation for future success.”
Mr Unsworth said: “There are exciting opportunities for B+L in this dynamic growth region. I look forward to working with our teams across Asia-Pacific to build high performance for our company, for our customers, and for patients.”